132
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Stability-Indicating Assay Method for Estimation of Olmesartan Medoxomil and its Metabolite

, , &
Pages 1516-1526 | Received 12 Nov 2008, Accepted 09 Jan 2009, Published online: 17 Apr 2009
 

Abstract

A novel stability indicating high performance liquid chromatographic assay method was developed and validated for Olmesartan medoxomil and its degradant product. An isocratic HPLC method was developed to separate the drug from the degradation products, using an Inertsil-ODS-3 (C-18) Column (5 µm, 250 mm × 4.60 mm). A mixture of phosphate buffer (pH 4.0) and methanol (30:70) was used as mobile phase. The flow rate was 1.0 mL/min and the detection was carried out at 230 nm. The validation studies were carried out fulfilling the International Conference on Harmonisation (ICH) requirements. The procedure was found to be specific, linear, precise (including intra and inter day precision), accurate, and robust.

ACKNOWLEDGMENTS

We wish thank to Sophisticated Analytical Instruments Facility, Indian Institute of Technology, Mumbai for providing us LC-MS/MS facility. We would like to thank Glenmark Pharmaceuticals Ltd. (Mumbai, India) for providing gift samples of Olmesartan medoxomil.

Notes

a S.D. = Standard deviation.

b R.S.D. = Relative standard deviation.

c n = Number of determination.

a S.D. = Standard deviation.

b R.S.D. = Relative standard deviation.

c n = Number of determination.

a S.D. = Standard deviation.

b R.S.D. = Relative standard deviation.

c n = Number of determination.

a S.D. = Standard deviation.

b R.S.D. = Relative standard deviation.

c n = Number of determination.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.